AI Article Synopsis
- Researchers synthesized and characterized new compounds called 6-substituted pyrazolo[3,4-d]pyrimidines and pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidines.
- These compounds were tested for their effectiveness against Abl and Src kinases in vitro.
- Compounds 7a and 7b showed the strongest activity against both wild and mutant Abl kinases, as well as the Src kinase and the leukemia K-562 cell line, indicating potential for further development.
Article Abstract
Some novel 6-substituted pyrazolo[3,4-d]pyrimidines 4, 5, 6a-d, 7a-c, 8 and pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidines 9a-c, 10a-c, 11, 12a,b, 13a-c and 14 were synthesized and characterized by spectral and elemental analyses. They were screened for their biological activity in vitro against Abl and Src kinases. Compounds 7a and 7b revealed the highest activity against both wild and mutant Abl kinases as well as the Src kinase and the leukemia K-562 cell line. They can be considered as new hits for further structural optimization to obtain better activity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejmech.2016.07.034 | DOI Listing |
Publication Analysis
Top Keywords
novel pyrazolo[34-d]pyrimidines
4
pyrazolo[34-d]pyrimidines dual
4
dual src-abl
4
src-abl inhibitors
4
inhibitors active
4
active mutant
4
mutant form
4
form abl
4
abl leukemia
4
leukemia k-562
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!